
Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.

September 11, 2023
As a drug developer, you have to live with the answers and comments you get from regulatory authorities. Therefore,...
Read article

June 20, 2023
New FDA Guidelines on Pediatric Studies and Potential Effects on Opportunities for Market Exclusivity
Legislation on pediatric studies has existed for more than 20 years in the US, yet additional guidance from the FDA has...
Read article